Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, Gwangju, Korea.
Korean J Anesthesiol. 2010 May;58(5):435-9. doi: 10.4097/kjae.2010.58.5.435. Epub 2010 May 29.
Microemulsion propofol produces more frequent and severe pain upon injection than lipid emulsion propofol. This study examined the analgesic effect of lidocaine-premixed microemulsion propofol in patients pretreated with remifentanil. The induction of anesthesia with this combination was compared with microemulsion propofol accompanied with either remifentanil or lidocaine.
One hundred twenty patients aged between 20-65 years old were allocated randomly into one of three groups (n = 40, in each). The patients in the remifentanil group received remifentanil 0.5 microg/kg IV for 30 seconds before a microemulsion propofol injection. The patients in the lidocaine group received propofol 2 mg/kg premixed with 40 mg lidocaine over a 60 second period. The patients in the combination group received both remifentanil and lidocaine.
There was a significantly lower incidence of microemulsion propofol injection pain (severity 2 or more) in the combination group (12.5%) than in the remifentanil and lidocaine groups (90% and 65%, respectively, P < 0.05). The incidence of moderate pain disappeared completely in the combination group (0%) compared to that in the remifentanil and lidocaine group (32.5% and 20%, respectively, P < 0.05). Severe pain did not appear in any of the three groups. There were no complications on the injection site in the lidocaine alone and combination groups.
The combination of microemulsion propofol premixed with lidocaine after a pretreatment with remifentanil was more effective in reducing the incidence of pain upon the injection of microemulsion propofol than either treatment alone.
与脂质乳剂丙泊酚相比,微乳液丙泊酚注射时疼痛更频繁且更剧烈。本研究旨在观察预先给予瑞芬太尼的情况下利多卡因预混微乳丙泊酚的镇痛效果。比较了这种联合麻醉诱导与单独使用瑞芬太尼或利多卡因的微乳丙泊酚的效果。
120 名年龄在 20-65 岁之间的患者被随机分为三组(每组 40 名)。瑞芬太尼组患者在微乳丙泊酚注射前 30 秒内静脉注射瑞芬太尼 0.5μg/kg。利多卡因组患者在 60 秒内静脉注射 2mg/kg 丙泊酚,同时预混 40mg 利多卡因。联合组患者同时给予瑞芬太尼和利多卡因。
联合组微乳丙泊酚注射疼痛(严重程度 2 级或更严重)发生率明显低于瑞芬太尼和利多卡因组(分别为 12.5%和 90%、65%,P<0.05)。联合组中度疼痛的发生率完全消失(0%),而瑞芬太尼和利多卡因组分别为 32.5%和 20%(P<0.05)。三组均未出现重度疼痛。利多卡因组和联合组注射部位均无并发症。
预先给予瑞芬太尼后,微乳液丙泊酚与利多卡因预混,可更有效地降低微乳液丙泊酚注射疼痛的发生率,优于单独使用任一种药物。